Renaissance BioScience Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1M
Latest Deal Amount
  • Investors
  • 4

Renaissance BioScience General Information

Description

Operator of a bioengineering company intended to develop a novel platform technology for the oral delivery of RNAi. The company's technology targets the reduction of inflammation for Crohn's disease, Ulcerative colitis, or other gastrointestinal diseases, it also has applications in animal health and environmentally friendly biopesticides, its products include yeast strains that prevent the formation of naturally occurring contaminants, enabling snack food industries to deliver things that need to supply, sustain and strengthen humanity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 410-2389 Health Sciences Mall
  • The University of British Columbia
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604) 000-0000

Renaissance BioScience Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Renaissance BioScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2021 $1M 000.00 Completed Pre-Clinical Trials
5. Grant 01-Jan-2020 00.000 000.00 Completed Startup
4. Accelerator/Incubator 01-Oct-2019 000 000.00 Completed Pre-Clinical Trials
3. Seed Round 00.00 00.00 000.00 Completed Pre-Clinical Trials
2. Grant 08-Jun-2017 $370K Completed Pre-Clinical Trials
1. Grant 01-Mar-2016 $50K Completed Startup
To view Renaissance BioScience’s complete valuation and funding history, request access »

Renaissance BioScience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a bioengineering company intended to develop a novel platform technology for the oral delivery of RNAi. The
Biotechnology
Vancouver, Canada
19 As of 2021
000.00
0000000000 000.00

00000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000000
Bagsvaerd, Denmark
0000 As of 0000
00000000

0000000

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000000
Roslin, United Kingdom
0 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renaissance BioScience Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novozymes Corporation Bagsvaerd, Denmark 0000 00000000
0000000 Corporation Roslin, United Kingdom 0 0000000000
000000000 Venture Capital-Backed Lutherville Timonium, MD 0 000.00 0000000000 0 000.00
000000000 0000 Venture Capital-Backed Madison, WI 00 00.000 0000000000 00.000
0000000000 0000000 Venture Capital-Backed Medford, MA 000 00000 0000000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Renaissance BioScience Executive Team (10)

Name Title Board Seat Contact Info
John Husnik Ph.D Co-Founder, Chief Executive Officer, CSO & Board Member
Michael Kirwan Chief Financial Officer
Maurice Boucher Co-Founder & Executive Chairman
You’re viewing 3 of 10 executive team members. Get the full list »

Renaissance BioScience Board Members (7)

Name Representing Role Since
John Husnik Ph.D Renaissance BioScience Co-Founder, Chief Executive Officer, CSO & Board Member 000 0000
Maurice Boucher Renaissance BioScience Co-Founder & Executive Chairman 000 0000
Morris Chen Renaissance BioScience Board Member 000 0000
Peter Lutwyche Ph.D Self Board Member 000 0000
Vick Dusik Renaissance BioScience Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Renaissance BioScience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Renaissance BioScience Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Radicle Accelerator/Incubator Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
Carpere Capital PE/Buyout Minority 000 0000 000000 0
NorthView Lifesciences Venture Capital Minority 000 0000 000000 0
To view Renaissance BioScience’s complete investors history, request access »